Connection

Miguel Abboud to Adult

Back to Details
This is a "connection" page, showing publications Miguel Abboud has written about Adult.
Miguel Abboud
Connection Strength
0.557
Adult
  1. Voxelotor for the treatment of sickle cell disease in pediatric patients. Expert Rev Hematol. 2022 06; 15(6):485-492.
    View in: PubMed
    Score: 0.056
  2. Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia. Curr Res Transl Med. 2017 09; 65(3):115-119.
    View in: PubMed
    Score: 0.041
  3. Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
    View in: PubMed
    Score: 0.031
  4. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol. 2012 Jul; 87(7):678-83.
    View in: PubMed
    Score: 0.028
  5. Stem-cell transplantation in children and adults with sickle cell disease: an update. Expert Rev Hematol. 2011 Jun; 4(3):343-51.
    View in: PubMed
    Score: 0.026
  6. Bereaved parental evaluation of the quality of a palliative care program in Lebanon. Pediatr Blood Cancer. 2011 Aug; 57(2):310-6.
    View in: PubMed
    Score: 0.026
  7. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease. Pediatr Blood Cancer. 2010 Dec 15; 55(7):1338-42.
    View in: PubMed
    Score: 0.025
  8. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatr Blood Cancer. 2010 Mar; 54(3):398-402.
    View in: PubMed
    Score: 0.024
  9. Hematopoietic stem-cell transplantation for adults with sickle cell disease. N Engl J Med. 2009 Dec 10; 361(24):2380-1.
    View in: PubMed
    Score: 0.024
  10. Limb salvage surgery for children and adolescents with malignant bone tumors in a developing country. Pediatr Blood Cancer. 2008 Dec; 51(6):787-91.
    View in: PubMed
    Score: 0.022
  11. Venous sinus thrombosis leading to stroke in a patient with sickle cell disease on hydroxyurea and high hemoglobin levels: treatment with thrombolysis. Am J Hematol. 2008 Oct; 83(10):818-20.
    View in: PubMed
    Score: 0.022
  12. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Haematol. 2021 May; 8(5):e334-e343.
    View in: PubMed
    Score: 0.013
  13. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA. 2021 04 20; 325(15):1513-1523.
    View in: PubMed
    Score: 0.013
  14. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol. 2021 04 01; 96(4):404-417.
    View in: PubMed
    Score: 0.013
  15. Elevated serum and bronchoalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br J Haematol. 2000 Nov; 111(2):482-90.
    View in: PubMed
    Score: 0.013
  16. Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT). Bone Marrow Transplant. 2020 07; 55(7):1485-1490.
    View in: PubMed
    Score: 0.012
  17. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
    View in: PubMed
    Score: 0.011
  18. Prognostic significance of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase-1 (IDH-1) mutation in glioblastoma multiforme patients: A single-center experience in the Middle East region. Clin Neurol Neurosurg. 2019 07; 182:92-97.
    View in: PubMed
    Score: 0.011
  19. Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study. Br J Haematol. 2019 01; 184(2):269-278.
    View in: PubMed
    Score: 0.011
  20. Granulocytosis causing sickle-cell crisis. Lancet. 1998 Mar 28; 351(9107):959.
    View in: PubMed
    Score: 0.010
  21. Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management. Pediatr Blood Cancer. 2017 Dec; 64(12).
    View in: PubMed
    Score: 0.010
  22. Trends in hematopoietic stem cell transplant activity in Lebanon. Hematol Oncol Stem Cell Ther. 2017 Dec; 10(4):315-320.
    View in: PubMed
    Score: 0.010
  23. Transient therapy-related myelodysplastic syndrome associated with monosomy 7 and 11q23 translocation. Leukemia. 1997 Mar; 11(3):448-50.
    View in: PubMed
    Score: 0.010
  24. Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis. Genome Med. 2015 Dec 18; 7:130.
    View in: PubMed
    Score: 0.009
  25. A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2014 Jul; 89(7):709-13.
    View in: PubMed
    Score: 0.008
  26. Cytomegalovirus retinitis in children and young adults with acute lymphoblastic leukemia in Lebanon. Leuk Lymphoma. 2014 Aug; 55(8):1918-21.
    View in: PubMed
    Score: 0.008
  27. Priapism, an emerging complication in ?-thalassemia intermedia patients. Hemoglobin. 2014; 38(5):351-4.
    View in: PubMed
    Score: 0.008
  28. A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. Am J Hematol. 2013 Nov; 88(11):E255-60.
    View in: PubMed
    Score: 0.008
  29. Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models. Pediatr Hematol Oncol. 2011 Nov; 28(8):676-81.
    View in: PubMed
    Score: 0.007
  30. Complementary and alternative medicine use among pediatric patients with leukemia: the case of Lebanon. Integr Cancer Ther. 2011 Mar; 10(1):38-46.
    View in: PubMed
    Score: 0.006
  31. Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin. 2006; 30(2):165-70.
    View in: PubMed
    Score: 0.004
  32. Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin. 2004 May; 28(2):85-102.
    View in: PubMed
    Score: 0.004
  33. Effective treatment of hypereosinophilic syndrome with imatinib mesylate. Hematol J. 2003; 4(6):410-2.
    View in: PubMed
    Score: 0.004
  34. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood. 2000 May 15; 95(10):3057-64.
    View in: PubMed
    Score: 0.003
  35. Costs, charges, and reimbursements for persons with sickle cell disease. J Pediatr Hematol Oncol. 1999 Sep-Oct; 21(5):389-96.
    View in: PubMed
    Score: 0.003
  36. Postdural puncture headache in paediatric oncology patients. Can J Anaesth. 1998 Aug; 45(8):741-5.
    View in: PubMed
    Score: 0.003
  37. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997 Mar 01; 89(5):1533-42.
    View in: PubMed
    Score: 0.002
  38. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995 Jul 27; 333(4):206-13.
    View in: PubMed
    Score: 0.002
  39. Adult Wilms' tumor: prognostic and management considerations. Urology. 1995 Jun; 45(6):1055-8.
    View in: PubMed
    Score: 0.002
  40. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
    View in: PubMed
    Score: 0.002
  41. Impact of laparoscopic cholecystectomy on the management of cholelithiasis in children with sickle cell disease. J Pediatr Surg. 1994 Feb; 29(2):209-12; discussion 212-3.
    View in: PubMed
    Score: 0.002
  42. Measurement of marrow repopulating potential of human hematopoietic progenitor and stem cells using a fetal sheep model. Prog Clin Biol Res. 1994; 389:281-91.
    View in: PubMed
    Score: 0.002
  43. Ex vivo expansion of CD34+ cells from purified adult human bone marrow and umbilical cord blood hematopoietic progenitor cells. Prog Clin Biol Res. 1994; 389:385-91.
    View in: PubMed
    Score: 0.002
  44. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts? Blood Cells. 1994; 20(2-3):382-90; discussion 390-1.
    View in: PubMed
    Score: 0.002
  45. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. J Pediatr. 1990 Apr; 116(4):627-32.
    View in: PubMed
    Score: 0.002
  46. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med. 1989 06 15; 320(24):1574-80.
    View in: PubMed
    Score: 0.001
  47. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Exp Hematol. 1989 Feb; 17(2):191-7.
    View in: PubMed
    Score: 0.001
  48. Five related Lebanese individuals with high plasma lysosomal hydrolases: a new defect in mannose-6-phosphate receptor recognition? Am J Hum Genet. 1984 Sep; 36(5):1001-14.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.